Generation of induced pluripotent stem cells and gene correction

By Michela Deleidi, MD, PhD
View Published Protocol

Output Details

Description
iPSC generation and gene correction (CRISPR-CAS9) protocol
Identifier (DOI)
10.17504/protocols.io.5jyl8jo89g2w/v1
Tags
  • CRISPR
Team
Team Schapira
Program
Collaborative Research Network
Theme
Neuro-Immune Interactions

Meet the Authors

Related Research

Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism

Mutations in GBA1, the gene encoding the lysosomal enzyme β-glucocerebrosidase (GCase), which cause Gaucher’s disease, are the most frequent genetic risk factor for Parkinson’s disease (PD). Here, we employ global proteomic and single-cell…

View Article

LINE-1 retrotransposons regulate the exit of human pluripotency and early brain development (Preprint)

Hominoid-specific L1 retrotransposons are expressed in human stem cells and organoids. Silencing L1s leads to changes in neural differentiation and organoid size, suggesting L1 involvement in central nervous system development.

View Article

CRISPR tagging of the TMEM192 gene with 3xHA in H9 ES AAVS-NGN2 cells for Lyso-IP

Protocol for adding a 3X HA tag to TMEM192 gene in human cells using CAS9 and recombination template is described for H9 ES AAVS1-NGN2 cells.

View Protocol
View More Outputs